{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:36:39Z","timestamp":1777462599270,"version":"3.51.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Lab Res"],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.1007\/s005990070014","type":"journal-article","created":{"date-parts":[[2003,2,13]],"date-time":"2003-02-13T01:54:09Z","timestamp":1045101249000},"page":"147-156","source":"Crossref","is-referenced-by-count":21,"title":["Role of platelets in tissue factor expression by monocytes in normal and hypercholesterolemic subjects. In vitro effect of cerivastatin"],"prefix":"10.1007","volume":"30","author":[{"given":"L.","family":"Puccetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Cercignani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Pompella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Auteri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. L.","family":"Pasqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"303147_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V71.1.1.1","volume":"71","author":"Y Nemerson","year":"1988","unstructured":"Nemerson Y. Tissue factor and haemostasis. Blood 1988; 71:1.","journal-title":"Blood"},{"key":"303147_CR2","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1161\/01.ATV.12.10.1111","volume":"12","author":"SI Rapaport","year":"1992","unstructured":"Rapaport SI, Rao LV. Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb 1992; 12:1111.","journal-title":"Arterioscler Thromb"},{"key":"303147_CR3","first-page":"1566","volume-title":"Hematology. Basic principles and clinical practice","author":"B Furie","year":"1995","unstructured":"Furie B, Furie BC. Molecular basis of blood coagulation. In: Hoffman R, Benz Jr EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, eds. Hematology. Basic principles and clinical practice, 2nd edn. New York: Churchchill Livingstone; 1995; 1566\u20131587.","edition":"2nd edn."},{"key":"303147_CR4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-0038-1657510","volume":"78","author":"KA Bauer","year":"1997","unstructured":"Bauer KA. Activation of the factor VII-Tissue Factor pathway. Thromb Haemost 1997; 78:108.","journal-title":"Thromb Haemost"},{"key":"303147_CR5","first-page":"19","volume-title":"Hemostasis and thrombosis: basic principles and clinical practice","author":"A Ichinose","year":"1994","unstructured":"Ichinose A, Davie EW. The blood coagulation factors: their cDNAs, genes and expression. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and thrombosis: basic principles and clinical practice, 3rd edn. Philadelphia: Lippincott; 1994: 19\u201354.","edition":"3rd edn"},{"key":"303147_CR6","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1182\/blood.V73.4.968.968","volume":"73","author":"HJ Weiss","year":"1989","unstructured":"Weiss HJ, Turitto VT, Baumgartner HR, Nemerson Y, Hoffman T. Evidence for the presence of tissue factor activity on subendothelium. Blood 1989; 73:968.","journal-title":"Blood"},{"key":"303147_CR7","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1073\/pnas.86.8.2839","volume":"86","author":"JN Wilcox","year":"1989","unstructured":"Wilcox JN, Smith KN, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel and in the atherosclerotic plaque. Proc Natl Acad Sci U S A 1989; 86:2839.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"303147_CR8","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1073\/pnas.83.10.3460","volume":"83","author":"PP Nawroth","year":"1986","unstructured":"Nawroth PP, Handley DA, Esmon CT, Stern DM. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci U S A 1986; 83:3460.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"303147_CR9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2141.1984.tb02892.x","volume":"57","author":"JH Brox","year":"1984","unstructured":"Brox JH, Osterud B, Bjorklid E, Fenton JW. Production and availability of thromboplastin in endothelial cells. The effects of thrombin, endotoxin and platelets. Br J Haematol 1984; 57:239.","journal-title":"Br J Haematol"},{"key":"303147_CR10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2141.1975.tb00547.x","volume":"30","author":"RPA Rivers","year":"1975","unstructured":"Rivers RPA, Hathaway WE, Weston WL. The endotoxin-induced coagulant activity of human monocytes. Br J Haematol 1975; 30:311.","journal-title":"Br J Haematol"},{"key":"303147_CR11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-0609.1982.tb00580.x","volume":"29","author":"B \u00d8sterud","year":"1982","unstructured":"\u00d8sterud B, Bjorklid E. The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. An assay for detection of endotoxin. Scand J Haematol 1982; 29:175.","journal-title":"Scand J Haematol"},{"key":"303147_CR12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2141.1982.tb02827.x","volume":"51","author":"T Lybeg","year":"1982","unstructured":"Lybeg T, Nilsson K, Prydz H. Synthesis of thromboplastin by U937 cells. Br J Haematol 1982; 51:631.","journal-title":"Br J Haematol"},{"key":"303147_CR13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-0038-1646375","volume":"66","author":"TS Edgington","year":"1991","unstructured":"Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost 1991; 66:67.","journal-title":"Thromb Haemost"},{"key":"303147_CR14","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1084\/jem.174.6.1517","volume":"174","author":"N Mackman","year":"1994","unstructured":"Mackman N, Brand K, Edgington TS. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kB binding sites. J Exp Med 1994; 174:1517.","journal-title":"J Exp Med"},{"key":"303147_CR15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R. Atherosclerosis. An inflammatory disease. N Engl J Med 1999; 340:115.","journal-title":"N Engl J Med"},{"key":"303147_CR16","first-page":"181","volume":"183","author":"RG Gerrity","year":"1981","unstructured":"Gerrity RG. The role of monocyte in atherogenesis. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 1981; 183:181.","journal-title":"Am J Pathol"},{"key":"303147_CR17","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1146\/annurev.ph.57.030195.004043","volume":"57","author":"R Ross","year":"1995","unstructured":"Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 1995; 57:791.","journal-title":"Annu Rev Physiol"},{"key":"303147_CR18","first-page":"1565","volume":"92","author":"PK Shah","year":"1995","unstructured":"Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G, Fallon JT, Rengstrom J, Fuster V. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995; 92:1565.","journal-title":"Circulation"},{"key":"303147_CR19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/s-0038-1657534","volume":"78","author":"V Fuster","year":"1997","unstructured":"Fuster V, Fallon JT, Badimon JJ, Nemerson Y. The unstable atherosclerotic plaque; clinical significance and therapeutic intervention. Thromb Haemost 1997; 78:247.","journal-title":"Thromb Haemost"},{"key":"303147_CR20","first-page":"492","volume-title":"Atherosclerosis and coronary artery disease, Vol. 2","author":"E Falk","year":"1996","unstructured":"Falk E, Shah PK, Fuster V. Pathogenesis of plaque disruption. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease, Vol. 2. Philadelphia: Lippincott-Raven; 1996: 492\u2013510."},{"key":"303147_CR21","first-page":"539","volume-title":"Atherosclerosis and coronary artery disease, Vol. 1","author":"EW Raines","year":"1996","unstructured":"Raines EW, Rosenfeld ME, Ross R. The role of macrophages. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease, Vol. 1. Philadelphia: Lippincott-Raven; 1996: 539\u2013555."},{"key":"303147_CR22","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1161\/01.CIR.94.12.3090","volume":"94","author":"PR Moreno","year":"1996","unstructured":"Moreno PR, Bernardi VH, Lopez-Cuellar J, Murcia AM, Palacios IF, Gold HK, Mehran R, Sharma SK, Nemerson Y, Fuster V, Fallon JT. Macrophages, smooth muscle cells and tissue factor in unstable angina: implications for cell mediated thrombogenicity in acute coronary syndromes. Circulation 1996; 94:3090.","journal-title":"Circulation"},{"key":"303147_CR23","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1161\/01.CIR.96.2.396","volume":"96","author":"F Mach","year":"1997","unstructured":"Mach F, Schondbeckm U, Bonnefoy JY, Pober JS, Libby P. Activation of monocyte\/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin and tissue factor. Circulation 1997; 96: 396.","journal-title":"Circulation"},{"issue":"Suppl 1","key":"303147_CR24","first-page":"9","volume":"9","author":"B \u00d8sterud","year":"1998","unstructured":"\u00d8sterud B. Tissue Factor expression by monocytes: regulation and pathophysiological roles. Blood Coagul Fibrinolysis 1998; 9[Suppl 1]:9.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"303147_CR25","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/s-0037-1614527","volume":"81","author":"S Colli","year":"1999","unstructured":"Colli S, Lalli M, Ris\u00e8 P, Mussoni L, Eligini S, Galli C, Tremoli E. Increased thrombogenic potential of human monocyte-derived macrophages spontaneously transformed into foam cells. Thromb Haemost 1999; 81:576.","journal-title":"Thromb Haemost"},{"key":"303147_CR26","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1172\/JCI107891","volume":"54","author":"J Niemetz","year":"1974","unstructured":"Niemetz J, Marcus AJ. The stimulatory effect of platelets and platelet membranes on the procoagulant effect of leukocytes. J Clin Invest 1974; 54:1437.","journal-title":"J Clin Invest"},{"key":"303147_CR27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/09537109509013263","volume":"6","author":"B \u00d8sterud","year":"1995","unstructured":"\u00d8sterud B. The high responder phenomenon: enhancement of LPS-induced tissue factor activity in monocytes by platelets and granulocytes. Platelets 1995; 6:119.","journal-title":"Platelets"},{"key":"303147_CR28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00001721-199003000-00007","volume":"1","author":"B \u00d8sterud","year":"1990","unstructured":"\u00d8sterud B, Olsen JO, Wilsgard L. The role of arachidonic acid release and lipoxygenase pathway in lipopolysaccharide induced thromboplastin activity in monocytes. Blood Coagul Fibrinolysis 1990; 1:41.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"303147_CR29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jlb.54.4.275","volume":"54","author":"H Halvorsen","year":"1993","unstructured":"Halvorsen H, Olsen JO, Osterud B. Granulocytes enhance LPS-induced tissue factor activity in monocytes via an interaction with platelets. J Leukoc Biol 1993; 54:275.","journal-title":"J Leukoc Biol"},{"key":"303147_CR30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0038-1650226","volume":"75","author":"A Amirkhosravi","year":"1996","unstructured":"Amirkhosravi A, Alexander M, May K, Francis DA, Warnes G, Biggerstaff J, Francis JL. The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay. Thromb Haemost 1996; 75:87.","journal-title":"Thromb Haemost"},{"key":"303147_CR31","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/jlb.58.5.575","volume":"58","author":"C Sissner Engstad","year":"1995","unstructured":"Sissner Engstad C, Lia K, Rekdal O, Olsen JO, Osterud B. A novel biological effect of platelet factor 4 (PF4): enhancement of LPS-induced tissue factor activity in monocytes. J Leukoc Biol 1995; 58:575.","journal-title":"J Leukoc Biol"},{"key":"303147_CR32","doi-asserted-by":"crossref","first-page":"8767","DOI":"10.1073\/pnas.91.19.8767","volume":"91","author":"A Celi","year":"1996","unstructured":"Celi A, Pellegrini G, Lorenzet R, De Blasi A, Ready N, Furie BC, Furie B. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A 1996; 91:8767.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"303147_CR33","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/jlb.51.5.462","volume":"51","author":"B \u00d8sterud","year":"1992","unstructured":"\u00d8sterud B. Platelet activating factor enhancement of lipopolysaccharide-induced tissue factor activity in monocytes: requirements of platelets and granulocytes. J Leukoc Biol 1992; 51:462.","journal-title":"J Leukoc Biol"},{"key":"303147_CR34","first-page":"108","volume":"15","author":"AD Muller","year":"1985","unstructured":"Muller AD, Dam-Mieras MCE van, Hemker HC. Measurement of macrophage cellular procoagulant activity. Haemostasis 1985; 15:108.","journal-title":"Haemostasis"},{"key":"303147_CR35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/01.ATV.17.2.265","volume":"17","author":"S Colli","year":"1997","unstructured":"Colli S, Eligini S, Lalli M, Camera M, Paoletti R, Tremoli R. Vastatins inhibit tissue factor in cultured human macrophages. A novel mechanism of protection against atherothrombosis. Arterioscler Thromb Vasc Biol 1997; 17:265.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"303147_CR36","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(05)63452-6","volume":"350","author":"D Ferro","year":"1997","unstructured":"Ferro D, Basili S, Alessandri C, Mantovani B, Cordova C, Violi F. Simvastatin reduces monocyte-tissue-factor expression in type IIa hypercholesterolaemia. Lancet 1997; 350:1222.","journal-title":"Lancet"},{"key":"303147_CR37","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/BF00878936","volume":"7","author":"CR Sirtori","year":"1993","unstructured":"Sirtori CR, Colli S. Influences of lipid-modifying agents on hemostasis. Cardiovasc Drugs Ther 1993; 7:817.","journal-title":"Cardiovasc Drugs Ther"},{"key":"303147_CR38","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(96)05190-2","volume":"348","author":"CJ Vaughan","year":"1996","unstructured":"Vaughan CJ, Murphy MB, Buckley BM. Statins do more than just lower cholesterol. Lancet 1996; 348:1079.","journal-title":"Lancet"},{"key":"303147_CR39","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1001\/jama.279.20.1643","volume":"279","author":"RS Rosenson","year":"1998","unstructured":"Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins. Implications for cardiovascular event reduction. JAMA 1998; 279:1643.","journal-title":"JAMA"},{"key":"303147_CR40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0049-3848(92)90132-T","volume":"68","author":"Y Calmus","year":"1992","unstructured":"Calmus Y, Robert A. Increased procoagulant activity in peripheral blood mononuclear cells from patients with liver cirrhosis. Thromb Res 1992; 68:103.","journal-title":"Thromb Res"},{"key":"303147_CR41","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.4049\/jimmunol.153.3.1328","volume":"153","author":"A Kornberg","year":"1995","unstructured":"Kornberg A, Blank M, Kaufman S. Induction of tissue-factor like activity in monocytes by anti-cardiolipin antibodies. J Immunol 1995; 153:1328.","journal-title":"J Immunol"},{"key":"303147_CR42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0076-6879(89)69045-3","volume":"169","author":"JF Mustard","year":"1989","unstructured":"Mustard JF, Kinlough-Rathbone RL, Packham MA. Isolation of human platelets from plasma by centrifugation and washing. Methods Enzymol 1989; 169:3.","journal-title":"Methods Enzymol"},{"key":"303147_CR43","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood.V83.9.2516.bloodjournal8392516","volume":"83","author":"K Meszaros","year":"1994","unstructured":"Meszaros K, Aberle S, Dedrick R. Monocyte tissue factor induction by lipopolysaccharide (LPS): dependence on LPS-binding protein and CD14, and inhibition by a recombinant fragment of bactericidal\/permeability-increasing protein. Blood 1994; 83:2516.","journal-title":"Blood"},{"key":"303147_CR44","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1084\/jem.159.4.1042","volume":"159","author":"BP Tsao","year":"1984","unstructured":"Tsao BP, Fair DS, Curtiss LK, Edgington TS. Monocytes can be induced by lipopolysaccharide-triggered T lymphocytes to express functional factor VII\/VIIa protease activity. J Exp Med 1984; 159:1042.","journal-title":"J Exp Med"},{"key":"303147_CR45","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/gut.43.3.428","volume":"43","author":"M Saliola","year":"1998","unstructured":"Saliola M, Lorenzet R, Ferro D, Basili F, Caroselli C, Di Santo A, Sallese M, Violi F. Enhanced expression of monocyte tissue factor in patients with liver cirrhosis. Gut 1998; 43:428.","journal-title":"Gut"},{"key":"303147_CR46","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dyebinding. Ann Biochem 1976; 72:248.","journal-title":"Ann Biochem"},{"key":"303147_CR47","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/jlb.51.5.462","volume":"51","author":"B \u00d8sterud","year":"1992","unstructured":"\u00d8sterud B. Platelet activating factor enhancement of lipopolysaccharide-induced tissue factor activity in monocytes: requirements of platelets and granulocytes. J Leukoc Biol 1992; 51:462.","journal-title":"J Leukoc Biol"},{"key":"303147_CR48","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1182\/blood.V86.1.212.bloodjournal861212","volume":"86","author":"RM Barstad","year":"1995","unstructured":"Barstad RM, Hamers MJAG, Stephens RW, Sakariassen KS. Retinoic acid reduces induction of monocyte tissue factor\/factor VIIa dependent arterial thrombus formation. Blood 1995; 86:212.","journal-title":"Blood"},{"key":"303147_CR49","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1113\/jphysiol.1963.sp007185","volume":"168","author":"GVR Born","year":"1963","unstructured":"Born GVR, Cross MJ. The aggregation of blood platelets. J Physiol 1963; 168:178.","journal-title":"J Physiol"},{"key":"303147_CR50","first-page":"210","volume":"53","author":"W Ritter","year":"1993","unstructured":"Ritter W, Frey R, Krol G. Rivastatin single dose pharmacokinetics. Clin Pharmacol Ther 1993; 53:210.","journal-title":"Clin Pharmacol Ther"},{"key":"303147_CR51","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM199201233260406","volume":"326","author":"V Fuster","year":"1992","unstructured":"Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326:242.","journal-title":"N Engl J Med"},{"key":"303147_CR52","first-page":"43","volume":"290","author":"ACA Carvalho","year":"1974","unstructured":"Carvalho ACA, Colman RW, Lees R. Platelet function in hyperlipoproteinemia. N Engl J Med 1974; 290:43.","journal-title":"N Engl J Med"},{"key":"303147_CR53","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0140-6736(79)90101-6","volume":"1","author":"E Tremoli","year":"1979","unstructured":"Tremoli E, Folco G, Agradi E, Galli C. Platelet, thromboxane and serum cholesterol. Lancet 1979; 1:107.","journal-title":"Lancet"},{"key":"303147_CR54","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0049-3848(88)90318-0","volume":"50","author":"D Prisco","year":"1988","unstructured":"Prisco D, Rogasi PG, Paniccia R, Coppo M, Abbate R, Gensini GF, Neri Serneri GG. Altered lipid composition and thromboxane A2 formation in platelets from patients affected by type IIa hyperlipoproteinemia. Thromb Res 1988; 50:593.","journal-title":"Thromb Res"},{"key":"303147_CR55","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1161\/01.CIR.85.5.1792","volume":"85","author":"G Dav\u00ec","year":"1992","unstructured":"Dav\u00ec G, Averna M, Catalano I, Barbagallo C, Ganci A, Ciabattoni C, Patrono C. Increased thromboxane biosynthesis in type IIa hypercholesterolemia. Circulation 1992; 85:1792.","journal-title":"Circulation"},{"key":"303147_CR56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-2007-994014","volume":"19","author":"E Tremoli","year":"1993","unstructured":"Tremoli E, Colli S, Maderna P, Baldassarre D, Di Minno G. Hypercholesterolemia and platelets. Semin Thromb Haemost 1993; 19:115.","journal-title":"Semin Thromb Haemost"},{"key":"303147_CR57","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1055\/s-0038-1649871","volume":"74","author":"G Dav\u00ec","year":"1995","unstructured":"Dav\u00ec G, Ganci A, Averna M, Giammarresi C, Barbagallo C, Catalano I, Cal\u00e0 A, Notarbartolo A. Thromboxane biosynthesis, neutrophil and coagulative activation in type IIa hypercholesterolemia. Thromb Haemost 1995; 74:1015.","journal-title":"Thromb Haemost"},{"key":"303147_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0009-8981(92)90216-D","volume":"213","author":"N Chetty","year":"1992","unstructured":"Chetty N, Naran NH. Platelet hyperreactivity in hyperlipidemia with specific reference to platelet lipids and fatty acid composition. Clin Chim Acta 1992; 213:1.","journal-title":"Clin Chim Acta"},{"key":"303147_CR59","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0735-1097(97)00129-0","volume":"30","author":"I Aoki","year":"1997","unstructured":"Aoki I, Aoki N, Kawano K, Shimoyama K, Maki A, Homori M, Yanagisawa A, Yamamoto M, Kaway Y, Ishikawa K. Platelet-dependent thrombin generation in patients with hyperlipidemia. J Am Coll Cardiol 1997; 30:91.","journal-title":"J Am Coll Cardiol"},{"key":"303147_CR60","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1161\/01.CIR.95.6.1370","volume":"95","author":"JR Nofer","year":"1997","unstructured":"Nofer JR, Tepel M, Kehrel B. Low-density lipoproteins inhibit the Na+\/H+ antiport in human platelets. A novel mechanism of enhancing platelet activity in hypercholesterolemia. Circulation 1997; 95:1370.","journal-title":"Circulation"},{"key":"303147_CR61","first-page":"1383","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","unstructured":"Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344:1383.","journal-title":"Lancet"},{"key":"303147_CR62","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","volume":"335","author":"FM Sacks","year":"1996","unstructured":"Sacks FM, Pfeffer MA, Moye LA. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335:1001.","journal-title":"N Engl J Med"},{"key":"303147_CR63","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","volume":"333","author":"J Shepherd","year":"1995","unstructured":"Shepherd J, Cobbe SM, Ford I. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333:1301.","journal-title":"N Engl J Med"}],"container-title":["International Journal of Clinical & Laboratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s005990070014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s005990070014\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s005990070014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T21:14:25Z","timestamp":1682284465000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s005990070014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["303147"],"URL":"https:\/\/doi.org\/10.1007\/s005990070014","relation":{},"ISSN":["0940-5437","1434-4467"],"issn-type":[{"value":"0940-5437","type":"print"},{"value":"1434-4467","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}